FDA Adverse Event Malfunction Summary report: N

PENUMBRA SYSTEM ACE 68 HI-FLOW KIT

MDR report key: 7100409 · Received December 8, 2017

Report

Report Number
3005168196-2017-02167
Event Type
Malfunction
Date Received
December 8, 2017
Date of Event
November 3, 2017
Report Date
November 10, 2017
Manufacturer
PENUMBRA, INC.
Product Code
NRY
UDI-DI
00814548016603
PMA / PMN Number
K161640
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TN, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

CORRECTION TO SECTION: CORRECTED "510(K) #¿ TO K161640.

Additional Manufacturer Narrative · 1

RESULTS: THE PENUMBRA SYSTEM ACE 68 REPERFUSION CATHETER (ACE68) WAS OVALIZED APPROXIMATELY 106.0 CM FROM THE HUB. CONCLUSIONS: EVALUATION OF THE RETURNED ACE68 REVEALED IT WAS OVALIZED. THIS DAMAGE MAY HAVE OCCURRED DUE TO FORCEFUL MANIPULATION OF THE ACE68 DURING NAVIGATION OF PATIENT ANATOMY. PENUMBRA CATHETERS ARE INSPECTED DURING IN-PROCESS INSPECTION AND DURING QUALITY INSPECTION AFTER MANUFACTURING. THE MANUFACTURING RECORDS FOR THIS LOT WERE REVIEWED AND DID NOT REVEAL ANY OUTSTANDING DISCREPANCIES, DESIGN, OR QUALITY CONCERNS.

Description of Event or Problem · 1

THE PATIENT WAS UNDERGOING A THROMBECTOMY PROCEDURE TO TREAT AN ACUTE ISCHEMIC STROKE USING A PENUMBRA SYSTEM ACE 68 HI-FLOW KIT (KIT). DURING THE PROCEDURE, A PENUMBRA SYSTEM ASPIRATION PUMP MAX 110 V (PUMP MAX) WAS TURNED ON, AND ASPIRATION BEGAN FOR APPROXIMATELY 90 SECONDS USING THE PENUMBRA SYSTEM ACE 68 REPERFUSION CATHETER (ACE68). AFTER THAT, WHILE USING DIRECT ASPIRATION FIRST PASS TECHNIQUE (ADAPT), THE PHYSICIAN WITHDREW THE ACE68 TO VISUALLY INSPECT THE CLOT; UPON REMOVING THE ACE68 FROM THE PATIENT, THE PHYSICIAN NOTICED THAT IT WAS KINKED. THEREFORE, THE PROCEDURE WAS SUCCESSFULLY COMPLETED USING A NEW ACE68. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
880277 PENUMBRA SYSTEM ACE 68 HI-FLOW KIT NRY NRY PENUMBRA, INC. F78619 00814548016603

Patients

Seq Age Sex Outcome Treatment
1 92 YR